News of Note—Pfizer, Serum Institute and more

In this week's vaccine News of Note, Pfizer reported third quarter results.

Here is some other vaccine news of note for this week.

> Pfizer reported vaccine sales that were up 1% over the same period last year. Key pneumococcal shot Prevnar 13 slipped by 1%. Release (PDF)

> Serum Institute of India hopes to more than double its revenue in the next five years and is eyeing sales in the U.S. in Europe. Economic Times story

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.

> The CDC's Advisory Committee on Immunization Practices recommended a third dose of a mumps-containing vaccine for those at risk during an outbreak. Washington Post story